Combination of radiation and razoxane (ICRF 159) in vivo

Metastases and the Normalization of Tumour Blood Vessels by ICRF 159: A New Type of Drug Action

1972 • 136 citations

Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic

1970 • 90 citations

Mode of Action of the Cytostatic Agent ‘ICRF 159’

1970 • 90 citations

The Enhanced Therapeutic Effect of <i>cis</i>-Platinum (II) Diamminodichloride against L1210 Leukemia when Combined with Cyclophosphamide or 1,2-bis(3,5-Dioxopiperazine-1-yl)propane or Several other Antitumor Agents

1973 • 70 citations

Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.

1974 • 68 citations

ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; Razoxane

1976 • 56 citations

Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors

1974 • 48 citations

Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159

1974 • 37 citations

Cell Proliferation and the Action of Cytotoxic Agents on Haemopoietic Tissue

1972 • 35 citations

Cumulative Cytostatic Effect of ICRF 159

1974 • 32 citations

Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line

1977 • 28 citations

Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159

1976 • 27 citations

Combined treatment of the Walker tumour with radiotherapy and ICRF 159

1974 • 20 citations

Strahlentherapie und ICRF 159 (NSC 129943) in der Behandlung inoperabler Weichteilsarkome

1974 • 6 citations

An improved apparatus for the measurement of oxygen concentration

1975 • 3 citations